Biomarkers, 2015
Effect of genetic and environmental factors on protein biomarkers for common non-communicable disease and use of personally normalized plasma protein profiles (PNPPP)

Enroth S., Bosdotter Enroth S., Johansson ?. et al.

Thrombosis Research, 2015
Associations between circulating proteins and corresponding genes expressed in coronary thrombi in patients with acute myocardial infarction

Helseth R., Weiss T., Opstad T. et al.

Stroke, 2015
Fibroblast Growth Factor 23 and Incidence of Subarachnoid Hemorrhage

Söderholm M., Engström G.

Journal of Pain Research, 2015
Evaluation of the protein biomarkers and the analgesic response to systemic methylene blue in patients with refractory neuropathic pain: a double-blind, controlled study

Miclescu A., Svahn M., Gordh T.

Cytokine, 2015
The body mass index (BMI) is significantly correlated with levels of cytokines and chemokines in cerebrospinal fluid

Larsson A., Carlsson L., Lind A. et al.

Atherosclerosis, 2015
Use of a proximity extension assay proteomics chip to discover new biomarkers for human atherosclerosis

Lind L., Ärnlöv J., Lindahl B. et al.

Arteriosclerosis, Thrombosis, and Vascular Biology, 2015
Elevated Plasma Levels of MMP-12 Are Associated With Atherosclerotic Burden and Symptomatic Cardiovascular Disease in Subjects With Type 2 Diabetes

Goncalves I., Bengtsson E., Colhoun H. et al.

Molecular Cancer Therapeutics, 2015
The Tyrosine Kinase Inhibitors Imatinib and Dasatinib Reduce Myeloid Suppressor Cells and Release Effector Lymphocyte Responses

Christiansson L., Söderlund S., Mangsbo S. et al.

Arteriosclerosis, Thrombosis, and Vascular Biology, 2014
High Plasma Levels of Heparin-Binding Epidermal Growth Factor Are Associated With a More Stable Plaque Phenotype and Reduced Incidence of Coronary Events

Rattik S., Wigren M., Björkbacka H. et al.

Brain, Behavior, and Immunity, 2014
Increased cerebrospinal fluid interleukin-8 in bipolar disorder patients associated with lithium and antipsychotic treatment

Isgren A., Jakobsson J., Pålsson E. et al.

Nature Communications, 2014
Strong effects of genetic and lifestyle factors on biomarker variation and use of personalized cutoffs

Enroth S., Johansson ?., Enroth S. et al.

Therapeutic Advances in Endocrinology and Metabolism, 2025
Novel therapeutic targets for metabolism-related diseases: proteomic Mendelian randomization and colocalization analyses

Zhang Y., Wang B., Chen B. et al.

Neurological Research, 2025
Mediators of the causal associations between protein ratios and ischemic stroke: a two-step Mendelian randomization study

Tan H., Chen H., Yan H. et al.

Menopause, 2023
The menopause-related gut microbiome: associations with metabolomics, inflammatory protein markers, and cardiometabolic health in women with HIV

Wang Y., Sharma A., Weber K. et al.

European Journal of Cancer, 2023
FOLFIRINOX chemotherapy modulates the peripheral immune landscape in pancreatic cancer: Implications for combination therapies and early response prediction

van Eijck C., Strijk G., Vietsch E. et al.

Nature Genetics, 2023
Genetics and epidemiology of mutational barcode-defined clonal hematopoiesis

Stacey S., Zink F., Halldorsson G. et al.

Journal of the American Heart Association, 2023
Proteomics and Precise Exercise Phenotypes in Heart Failure With Preserved Ejection Fraction: A Pilot Study

Shah R., Hwang S., Murthy V. et al.

Clinical and Experimental Dermatology, 2023
HLA-C*15:02 and epidermal growth factor receptor inhibitor-induced erosive pustular dermatosis of the scalp

Zhang Y., Grice S., Wang N. et al.

Neurobiology of Disease, 2023
Identification of diagnostic and prognostic biomarkers of PD using a multiplex proteomics approach

Maple-Grødem J., Ushakova A., Pedersen K. et al.

Nature Communications, 2023
Impact of dietary interventions on pre-diabetic oral and gut microbiome, metabolites and cytokines

Shoer S., Shilo S., Godneva A. et al.